
Baklava
- FlowerHybridTHC 24.28%
- Lab tested for potency and safety
- Category
- flower
- Lineage
- hybrid
- Brand
- Alien Labs
Looking for top-quality cannabis products? Look no further than Alien Labs, the premier source for all your cannabis needs. Whether you’re a medical marijuana patient or a recreational user, we have everything you need to enjoy the finest cannabis on the market. At Alien Labs, we are passionate about providing our customers with the very best cannabis products available. Our mission is to produce high-quality, innovative products that are both safe and sustainable. We use only the finest ingredients and cutting-edge technology to create our products, ensuring that you get the most out of every puff.
This product isn't available at your selected store right now. Check back later, or browse what's in stock.
Baklava is a hybrid flower from Alien Labs. The Baklava 3. 5g flower by Alien Labs is a premier, indoor-grown indica-dominant hybrid that masterfully bridges the gap between old-school "gas" and modern dessert profiles. Shop more from Alien Labs
Baklava is a hybrid. Hybrids combine indica and sativa genetics for a balance of body and mind effects. Learn more about strain lineage
Baklava tests at 24.28% THC. If you're new to cannabis or sensitive to THC, start with a small amount and give it time before having more. Learn more about dosing
Yes. You can order Baklava online for in-store pickup or delivery. Availability can vary by location. Learn more about delivery
Store Baklava in an airtight container somewhere cool, dark and dry. Heat, light and air dry flower out and fade its aroma and potency over time.
It can. Baklava contains THC, which standard drug tests look for, and THC can be detected for days or even weeks after use depending on how often you use it.
Yes. Purple Lotus is a licensed California dispensary, and like all legal cannabis in California, Baklava was tested by a state-licensed lab for potency and contaminants before it reached the shelf. It's for adults 21 and over.
